Julie Gralow, Chief Medical Officer of the American Society of Clinical Oncology, shared a post on LinkedIn:
“A cancer diagnosis is filled with uncertainty.
Our job as researchers is to help replace that uncertainty with hope.
Yet, when federal funding is unpredictable and unstable, care for the many thousands of cancer patients who participate in clinical trials of promising new treatments is delayed or derailed.
When trials are terminated, the result is heartbreaking: patients who have run out of treatment options are left to endure months of agonizing uncertainty.
Some never receive the last-chance treatment they need. Promising new ideas go unexplored. Life-saving breakthroughs are delayed.
Unstable and unpredictable federal cancer research funding is a grave problem for our patients, but thankfully, Congress is listening.
The bipartisan funding package introduced last week would increase funding for critical NIH and NCI research. Act now to tell Congress to pass this bill and help save American lives.”
More posts featuring Julie Gralow.